Skip to main content
Caplight Logo









AtoGen Co., Ltd.

AtoGen Co., Ltd.

Private
DaejeonHealthcare & Life Scienceshttps://atogen.kr/

Last Round

Strategic

Sep 15, 2022

Total Funding Raised

$14.06M

Company Overview

AtoGen Co., Ltd. is a biotechnology company that develops microbiome-based therapeutics and functional health ingredients using a proprietary screening platform and genomic analysis technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

live biotherapeutic productsLBPmicrobiome therapeuticsfunctional probioticsnutraceuticalsmicrobiome-based interventionsgenomic analysisdrug development pipelinegut healthmicrobiome researchbiotech R&Dprecision medicineprobiotic supplementsbacterial strain screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AtoGen Co., Ltd. Comparables

Compare AtoGen Co., Ltd. with similar companies based on industry and business-model similarity.

AtoGen Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enterobiome Inc.
80%
KoBioLabs Inc
79%
GI Longevity
79%

AtoGen Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicSep 15, 2022
VC RoundJan 3, 2022
Series AJan 1, 2020

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2020

    $7M round completed.

AtoGen Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

AtoGen Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AtoGen Co., Ltd.'s valuation, stock price, and market status.

Is AtoGen Co., Ltd. a public or private company?

AtoGen Co., Ltd. is a private company.

What is the current stock price of AtoGen Co., Ltd.?

AtoGen Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is AtoGen Co., Ltd. worth (valuation)?

Valuation information for AtoGen Co., Ltd. is not publicly available.

Can I buy AtoGen Co., Ltd. stock?

AtoGen Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AtoGen Co., Ltd.'s last funding round?

AtoGen Co., Ltd.'s most recent funding round was Strategic on September 15, 2022.

Who are the main investors in AtoGen Co., Ltd.?

Investor information for AtoGen Co., Ltd. is not publicly disclosed.

Will AtoGen Co., Ltd. IPO soon?

No public IPO plans have been announced for AtoGen Co., Ltd..

How can I track AtoGen Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AtoGen Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDaejeon
Year Founded2010
Last FundingSep 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?